Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
International Journal of Environmental Research and Public Health|May 28, 2022
Temperature Change between Neighboring Days Contributes to Years of Life Lost per Death from Respiratory Disease: A Multicounty Analysis in Central ChinaChun-Liang Zhou, Ling-Shuang Lv, Dong-Hui Jin, et al.
Theranostics|March 5, 2021
Environmental enrichment implies GAT-1 as a potential therapeutic target for stroke recoveryYuhui Lin, Mengcheng Yao, Haiyin Wu, et al.
Annals of Translational Medicine|October 21, 2022
Exosomes derived from umbilical cord mesenchymal stem cells protect cartilage and regulate the polarization of macrophages in osteoarthritisPengdong Li, Shuang Lv, Wenyue Jiang, et al.
Plos One|May 26, 2017
Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern ChinaXue Ke Zhao, Yi Min Mao, Hui Meng, et al.
Archives of Virology|August 9, 2020
Molecular characteristics of the capsid protein VP2 gene of canine parvovirus type 2 amplified from raccoon dogs in Hebei province, ChinaRongguang Lu, Yongle Yu, Xiangyu Zhu, et al.
Aging|September 19, 2023
Human umbilical cord mesenchymal stem cells-derived exosomes exert anti-inflammatory effects on osteoarthritis chondrocytesShichao Wang, Wenyue Jiang, Shuang Lv, et al.
Inflammation|May 23, 2012
Sulfated derivative of 20(S)-ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-induced RAW264.7 macrophagesWen-Yan Bi, Ben-Dong Fu, Hai-Qing Shen, et al.
Veterinary Immunology and Immunopathology|March 18, 2014
Inhibitory effects of α-cyperone on adherence and invasion of avian pathogenic Escherichia coli O78 to chicken type II pneumocytesLi-Yan Zhang, Shuang Lv, Shuai-Cheng Wu, et al.
Vaccines|May 28, 2022
A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 VariantsRui Wang, Chunyun Sun, Juan Ma, et al.
Virology|September 29, 2022
Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariantsRui Wang, Xun Huang, Tianshu Cao, et al.
Pageof 20